Digoxin protects against intervertebral disc degeneration via TNF/NF-κB and LRP4 signaling
BackgroundIntervertebral disc degeneration (IVDD) is a leading cause of low back pain (LBP). The pathological process of IVDD is associated with inflammatory reactions and extracellular matrix (ECM) disorders. Digoxin is widely used for treating heart failure, and it has been reported to have anti-i...
Main Authors: | Qunbo Meng, Kaiwen Liu, Zhenchuan Liu, Jinbo Liu, Ziyu Tian, Shanshan Qin, Jianlu Wei, Lei Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1251517/full |
Similar Items
-
Fexofenadine Protects Against Intervertebral Disc Degeneration Through TNF Signaling
by: Kaiwen Liu, et al.
Published: (2021-08-01) -
Serum digoxin concentrations in dogs with atrial fibrillation under long term digoxin treatment
by: Antonella Colella, et al.
Published: (2022-06-01) -
Safety profile of intravenous digoxin in Chinese patients with acute heart failure with reduced ejection fraction: a small-scale prospective cohort study
by: Xintian Liu, et al.
Published: (2023-11-01) -
Effects of Age, Gender, and Comorbid Diseases on Serum Digoxin Levels During Digoxin Treatment
by: Zeynep ÖZTÜRK, et al.
Published: (2018-01-01) -
RIPK1 suppresses apoptosis mediated by TNF and caspase-3 in intervertebral discs
by: Xubin Qiu, et al.
Published: (2019-04-01)